Hepatocyte growth factor: New arsenal in the fights against renal fibrosis?

62Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hepatocyte growth factor (HGF) has emerged as a potent, endogenous antifibrotic factor that shows an impressive efficacy in ameliorating tissue fibrosis in a wide variety of animal models. Herrero-Fresneda et al. provide new evidence demonstrating that intramuscular injection of HGF gene reduces mortality, inflammation, and renal fibrosis in chronic allograft nephropathy. © 2006 International Society of Nephrology.

Cite

CITATION STYLE

APA

Liu, Y., & Yang, J. (2006, July 7). Hepatocyte growth factor: New arsenal in the fights against renal fibrosis? Kidney International. Nature Publishing Group. https://doi.org/10.1038/sj.ki.5001661

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free